 Stephen Scott
Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parenting | 14 | 2025 | 319 | 3.010 |
Why?
| | Parent-Child Relations | 6 | 2024 | 285 | 1.900 |
Why?
| | Mothers | 4 | 2024 | 777 | 1.220 |
Why?
| | Child Behavior Disorders | 4 | 2021 | 142 | 1.140 |
Why?
| | Child Behavior | 4 | 2025 | 250 | 1.140 |
Why?
| | Conduct Disorder | 3 | 2019 | 187 | 1.080 |
Why?
| | Pregnancy in Adolescence | 3 | 2018 | 84 | 1.070 |
Why?
| | Mental Health | 7 | 2026 | 754 | 0.980 |
Why?
| | Problem Behavior | 6 | 2025 | 104 | 0.950 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2018 | 290 | 0.850 |
Why?
| | Mental Health Services | 3 | 2018 | 445 | 0.810 |
Why?
| | Vagina | 5 | 2024 | 188 | 0.810 |
Why?
| | Stomatitis, Aphthous | 1 | 2022 | 10 | 0.760 |
Why?
| | Vulvar Diseases | 1 | 2022 | 9 | 0.760 |
Why?
| | Patient-Centered Care | 2 | 2018 | 536 | 0.740 |
Why?
| | Adolescent Behavior | 5 | 2019 | 537 | 0.700 |
Why?
| | Virus Diseases | 1 | 2022 | 215 | 0.630 |
Why?
| | Child of Impaired Parents | 1 | 2019 | 41 | 0.620 |
Why?
| | Criminals | 2 | 2017 | 34 | 0.610 |
Why?
| | Schools | 5 | 2026 | 451 | 0.610 |
Why?
| | Program Development | 2 | 2018 | 364 | 0.600 |
Why?
| | Adolescent Health Services | 3 | 2019 | 77 | 0.590 |
Why?
| | Maternal-Child Health Services | 1 | 2018 | 11 | 0.590 |
Why?
| | Autistic Disorder | 4 | 2023 | 211 | 0.560 |
Why?
| | School Health Services | 3 | 2026 | 233 | 0.560 |
Why?
| | Students | 4 | 2026 | 645 | 0.560 |
Why?
| | Psychological Trauma | 1 | 2018 | 55 | 0.550 |
Why?
| | Video Recording | 2 | 2021 | 197 | 0.540 |
Why?
| | Early Medical Intervention | 1 | 2017 | 60 | 0.520 |
Why?
| | Parents | 10 | 2023 | 1440 | 0.520 |
Why?
| | Program Evaluation | 2 | 2018 | 919 | 0.520 |
Why?
| | Family Therapy | 1 | 2017 | 66 | 0.510 |
Why?
| | Depressive Disorder | 1 | 2019 | 374 | 0.500 |
Why?
| | Juvenile Delinquency | 1 | 2017 | 105 | 0.490 |
Why?
| | Adolescent | 27 | 2026 | 22064 | 0.470 |
Why?
| | Adolescent Medicine | 1 | 2015 | 29 | 0.470 |
Why?
| | Uterine Hemorrhage | 1 | 2015 | 38 | 0.470 |
Why?
| | Perinatal Care | 1 | 2016 | 60 | 0.470 |
Why?
| | Amenorrhea | 1 | 2014 | 31 | 0.440 |
Why?
| | Emergency Treatment | 1 | 2015 | 125 | 0.440 |
Why?
| | Depression | 2 | 2024 | 1489 | 0.430 |
Why?
| | Endometriosis | 1 | 2014 | 57 | 0.420 |
Why?
| | United Kingdom | 7 | 2023 | 321 | 0.420 |
Why?
| | Child | 27 | 2026 | 22342 | 0.410 |
Why?
| | Gynecology | 1 | 2015 | 178 | 0.400 |
Why?
| | Laparoscopy | 4 | 2018 | 463 | 0.370 |
Why?
| | Female | 40 | 2026 | 75727 | 0.360 |
Why?
| | Child, Preschool | 14 | 2025 | 11473 | 0.350 |
Why?
| | Bullying | 4 | 2026 | 44 | 0.350 |
Why?
| | Family | 3 | 2025 | 678 | 0.340 |
Why?
| | Humans | 49 | 2026 | 141265 | 0.310 |
Why?
| | Feasibility Studies | 9 | 2026 | 1025 | 0.310 |
Why?
| | Health Promotion | 2 | 2026 | 748 | 0.300 |
Why?
| | Depression, Postpartum | 2 | 2024 | 129 | 0.290 |
Why?
| | Pediatrics | 1 | 2015 | 1099 | 0.270 |
Why?
| | Uterine Cervicitis | 1 | 2006 | 7 | 0.250 |
Why?
| | England | 5 | 2026 | 108 | 0.240 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2005 | 40 | 0.230 |
Why?
| | Ligaments | 1 | 2005 | 74 | 0.220 |
Why?
| | Vaginitis | 1 | 2004 | 2 | 0.220 |
Why?
| | Hematocolpos | 1 | 2004 | 3 | 0.220 |
Why?
| | Vaginosis, Bacterial | 1 | 2004 | 11 | 0.220 |
Why?
| | Psychotherapy | 2 | 2019 | 184 | 0.220 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 418 | 0.220 |
Why?
| | Lordosis | 1 | 2024 | 16 | 0.210 |
Why?
| | Radiation Injuries | 1 | 2005 | 147 | 0.210 |
Why?
| | Pregnancy | 7 | 2024 | 7039 | 0.210 |
Why?
| | Cost-Benefit Analysis | 4 | 2022 | 612 | 0.210 |
Why?
| | Ovary | 1 | 2005 | 225 | 0.210 |
Why?
| | Sacrum | 1 | 2024 | 72 | 0.210 |
Why?
| | Hodgkin Disease | 1 | 2005 | 157 | 0.200 |
Why?
| | Adult | 13 | 2025 | 39201 | 0.200 |
Why?
| | Lumbar Vertebrae | 2 | 2024 | 251 | 0.200 |
Why?
| | Male | 22 | 2026 | 70061 | 0.200 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 27 | 0.200 |
Why?
| | Reactive Attachment Disorder | 1 | 2022 | 3 | 0.190 |
Why?
| | 46, XX Disorders of Sex Development | 1 | 2022 | 7 | 0.190 |
Why?
| | Child, Foster | 1 | 2022 | 12 | 0.190 |
Why?
| | Ulcer | 1 | 2022 | 34 | 0.190 |
Why?
| | Object Attachment | 2 | 2021 | 48 | 0.190 |
Why?
| | Obstetrics | 1 | 2024 | 176 | 0.180 |
Why?
| | Congenital Abnormalities | 1 | 2022 | 105 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2021 | 1605 | 0.170 |
Why?
| | Child Custody | 1 | 2021 | 6 | 0.170 |
Why?
| | Behavior Observation Techniques | 1 | 2021 | 10 | 0.170 |
Why?
| | Cost Savings | 1 | 2021 | 86 | 0.170 |
Why?
| | Occult Blood | 1 | 2020 | 37 | 0.170 |
Why?
| | Affective Symptoms | 1 | 2021 | 54 | 0.160 |
Why?
| | Breast Feeding | 1 | 2024 | 442 | 0.160 |
Why?
| | Stents | 1 | 2024 | 534 | 0.160 |
Why?
| | Accelerometry | 1 | 2021 | 109 | 0.160 |
Why?
| | Delayed Diagnosis | 1 | 2020 | 91 | 0.160 |
Why?
| | Sex Characteristics | 2 | 2024 | 786 | 0.150 |
Why?
| | Education, Nonprofessional | 1 | 2019 | 10 | 0.150 |
Why?
| | Colorado | 4 | 2018 | 4599 | 0.150 |
Why?
| | Research Design | 2 | 2017 | 1105 | 0.150 |
Why?
| | Personality Disorders | 1 | 2020 | 73 | 0.150 |
Why?
| | Pilot Projects | 6 | 2023 | 1815 | 0.150 |
Why?
| | Treatment Outcome | 6 | 2019 | 11194 | 0.150 |
Why?
| | Waiting Lists | 1 | 2020 | 245 | 0.140 |
Why?
| | Models, Statistical | 2 | 2020 | 670 | 0.140 |
Why?
| | Defecation | 1 | 2018 | 19 | 0.140 |
Why?
| | Colonoscopy | 1 | 2020 | 250 | 0.140 |
Why?
| | Rectal Prolapse | 1 | 2018 | 24 | 0.140 |
Why?
| | Feedback, Psychological | 1 | 2017 | 23 | 0.140 |
Why?
| | Home Care Services | 1 | 2021 | 260 | 0.140 |
Why?
| | Cross Infection | 1 | 2020 | 253 | 0.140 |
Why?
| | Infant Behavior | 1 | 2017 | 27 | 0.140 |
Why?
| | Young Adult | 6 | 2024 | 13665 | 0.140 |
Why?
| | Surgical Mesh | 1 | 2018 | 52 | 0.130 |
Why?
| | Adnexa Uteri | 1 | 2017 | 5 | 0.130 |
Why?
| | Torsion Abnormality | 1 | 2017 | 20 | 0.130 |
Why?
| | Anxiety | 2 | 2024 | 1078 | 0.130 |
Why?
| | Abdominal Pain | 2 | 2017 | 144 | 0.130 |
Why?
| | Digestive System Surgical Procedures | 1 | 2018 | 109 | 0.130 |
Why?
| | Behavior Therapy | 1 | 2019 | 282 | 0.130 |
Why?
| | Constipation | 1 | 2018 | 96 | 0.130 |
Why?
| | Rectum | 1 | 2018 | 187 | 0.120 |
Why?
| | Clinical Protocols | 1 | 2017 | 271 | 0.120 |
Why?
| | Norethindrone | 1 | 2015 | 2 | 0.120 |
Why?
| | Menstruation Disturbances | 1 | 2015 | 13 | 0.120 |
Why?
| | Contraceptives, Oral, Combined | 1 | 2015 | 18 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2024 | 1122 | 0.120 |
Why?
| | Health Status | 1 | 2021 | 822 | 0.120 |
Why?
| | Menorrhagia | 1 | 2015 | 22 | 0.120 |
Why?
| | Risk Assessment | 2 | 2020 | 3515 | 0.120 |
Why?
| | Crime Victims | 1 | 2017 | 130 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1335 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 375 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 371 | 0.110 |
Why?
| | Hematometra | 1 | 2014 | 5 | 0.110 |
Why?
| | Age Factors | 2 | 2024 | 3292 | 0.110 |
Why?
| | Orthopsychiatry | 1 | 2014 | 1 | 0.110 |
Why?
| | Group Homes | 1 | 2014 | 1 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2020 | 797 | 0.110 |
Why?
| | Child Rearing | 1 | 2014 | 29 | 0.110 |
Why?
| | Health Care Costs | 1 | 2017 | 418 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2923 | 0.100 |
Why?
| | Constriction, Pathologic | 2 | 2024 | 242 | 0.100 |
Why?
| | Aggression | 1 | 2015 | 194 | 0.100 |
Why?
| | Social Environment | 1 | 2015 | 294 | 0.100 |
Why?
| | Crime | 1 | 2013 | 60 | 0.100 |
Why?
| | Vaccination | 1 | 2022 | 1468 | 0.100 |
Why?
| | Telemedicine | 1 | 2022 | 888 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 809 | 0.090 |
Why?
| | Time Factors | 3 | 2018 | 6971 | 0.090 |
Why?
| | Infant | 4 | 2024 | 9801 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2023 | 2247 | 0.090 |
Why?
| | Feedback | 2 | 2022 | 178 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1493 | 0.080 |
Why?
| | Hydrocortisone | 1 | 2012 | 309 | 0.080 |
Why?
| | C-Reactive Protein | 1 | 2012 | 417 | 0.080 |
Why?
| | Mental Disorders | 1 | 2019 | 1124 | 0.080 |
Why?
| | Caregivers | 3 | 2023 | 940 | 0.080 |
Why?
| | Exercise | 1 | 2021 | 2108 | 0.070 |
Why?
| | Peer Group | 2 | 2024 | 247 | 0.070 |
Why?
| | Comorbidity | 2 | 2019 | 1672 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2014 | 3731 | 0.070 |
Why?
| | Child Abuse | 1 | 2012 | 546 | 0.060 |
Why?
| | False Positive Reactions | 1 | 2006 | 125 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 5937 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2024 | 16373 | 0.060 |
Why?
| | Dehydroepiandrosterone | 1 | 2006 | 51 | 0.060 |
Why?
| | Azithromycin | 1 | 2006 | 98 | 0.060 |
Why?
| | Emotions | 2 | 2021 | 575 | 0.060 |
Why?
| | Chronic Disease | 2 | 2018 | 1812 | 0.060 |
Why?
| | Neoplasms | 1 | 2020 | 2731 | 0.060 |
Why?
| | Electronics, Medical | 1 | 2004 | 13 | 0.060 |
Why?
| | Sexual Partners | 1 | 2006 | 187 | 0.060 |
Why?
| | Abdomen, Acute | 1 | 2004 | 22 | 0.060 |
Why?
| | Vaginal Diseases | 1 | 2024 | 19 | 0.050 |
Why?
| | Database Management Systems | 1 | 2004 | 51 | 0.050 |
Why?
| | Interviews as Topic | 2 | 2020 | 841 | 0.050 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2023 | 27 | 0.050 |
Why?
| | Family Conflict | 1 | 2024 | 43 | 0.050 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 2023 | 68 | 0.050 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2023 | 53 | 0.050 |
Why?
| | Siblings | 1 | 2024 | 216 | 0.050 |
Why?
| | Europe | 1 | 2024 | 407 | 0.050 |
Why?
| | Hymen | 1 | 2022 | 5 | 0.050 |
Why?
| | Vaginal Neoplasms | 1 | 2002 | 18 | 0.050 |
Why?
| | Endodermal Sinus Tumor | 1 | 2002 | 8 | 0.050 |
Why?
| | Mullerian Ducts | 1 | 2022 | 13 | 0.050 |
Why?
| | Pyrroles | 1 | 2023 | 209 | 0.050 |
Why?
| | Patient Selection | 1 | 2006 | 685 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1658 | 0.050 |
Why?
| | Decision Support Techniques | 1 | 2006 | 432 | 0.050 |
Why?
| | Communicable Disease Control | 1 | 2023 | 86 | 0.050 |
Why?
| | Uncertainty | 1 | 2023 | 137 | 0.050 |
Why?
| | Bone Density | 1 | 2006 | 496 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2024 | 7947 | 0.050 |
Why?
| | Patient Satisfaction | 1 | 2006 | 691 | 0.050 |
Why?
| | Dilatation | 1 | 2022 | 69 | 0.050 |
Why?
| | Goals | 1 | 2023 | 178 | 0.040 |
Why?
| | Focus Groups | 1 | 2024 | 567 | 0.040 |
Why?
| | Affect | 1 | 2024 | 312 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2023 | 215 | 0.040 |
Why?
| | Biopsy | 1 | 2004 | 1070 | 0.040 |
Why?
| | Biomarkers | 1 | 2012 | 4179 | 0.040 |
Why?
| | Immunochemistry | 1 | 2020 | 13 | 0.040 |
Why?
| | Interpersonal Relations | 1 | 2024 | 407 | 0.040 |
Why?
| | Life Tables | 1 | 2020 | 20 | 0.040 |
Why?
| | Wrist | 1 | 2021 | 58 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 284 | 0.040 |
Why?
| | Technology Assessment, Biomedical | 1 | 2020 | 39 | 0.040 |
Why?
| | Pyrimidines | 1 | 2023 | 511 | 0.040 |
Why?
| | Pyrazoles | 1 | 2023 | 482 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 112 | 0.040 |
Why?
| | Prevalence | 1 | 2006 | 2793 | 0.040 |
Why?
| | Critical Pathways | 1 | 2020 | 108 | 0.040 |
Why?
| | Forecasting | 1 | 2021 | 383 | 0.040 |
Why?
| | Infection Control | 1 | 2020 | 165 | 0.040 |
Why?
| | Personality Assessment | 1 | 2019 | 88 | 0.040 |
Why?
| | Psychopathology | 1 | 2019 | 58 | 0.040 |
Why?
| | Aged | 4 | 2024 | 24796 | 0.040 |
Why?
| | Curriculum | 1 | 2025 | 1030 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 360 | 0.030 |
Why?
| | Parovarian Cyst | 1 | 2017 | 2 | 0.030 |
Why?
| | Salpingectomy | 1 | 2017 | 15 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 278 | 0.030 |
Why?
| | Survival Analysis | 1 | 2020 | 1323 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2023 | 5213 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2018 | 367 | 0.030 |
Why?
| | Middle Aged | 4 | 2024 | 34595 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2006 | 1865 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2020 | 431 | 0.030 |
Why?
| | Models, Psychological | 1 | 2017 | 312 | 0.030 |
Why?
| | Aging | 1 | 2006 | 1921 | 0.030 |
Why?
| | Organizational Policy | 1 | 2015 | 76 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 950 | 0.030 |
Why?
| | Faculty | 1 | 2015 | 153 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 683 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2023 | 4413 | 0.020 |
Why?
| | Policy | 1 | 2014 | 146 | 0.020 |
Why?
| | Family Relations | 1 | 2013 | 90 | 0.020 |
Why?
| | Internet | 1 | 2017 | 682 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6262 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2095 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2024 | 2824 | 0.020 |
Why?
| | Consensus | 1 | 2014 | 546 | 0.020 |
Why?
| | Risk Factors | 2 | 2017 | 10482 | 0.020 |
Why?
| | Linear Models | 1 | 2013 | 855 | 0.020 |
Why?
| | Social Behavior | 1 | 2013 | 287 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3343 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 7787 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2013 | 1269 | 0.020 |
Why?
| | United States | 1 | 2006 | 15243 | 0.020 |
Why?
| | Qualitative Research | 1 | 2015 | 1526 | 0.020 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2006 | 42 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2006 | 56 | 0.020 |
Why?
| | Hip | 1 | 2006 | 57 | 0.020 |
Why?
| | Placebos | 1 | 2006 | 195 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5651 | 0.010 |
Why?
| | Quality of Life | 1 | 2018 | 3021 | 0.010 |
Why?
| | Hormone Replacement Therapy | 1 | 2006 | 102 | 0.010 |
Why?
| | Femur | 1 | 2006 | 260 | 0.010 |
Why?
| | Vitamin D | 1 | 2006 | 392 | 0.010 |
Why?
| | Body Composition | 1 | 2006 | 703 | 0.010 |
Why?
| | Salvage Therapy | 1 | 2002 | 154 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2006 | 1980 | 0.010 |
Why?
| | Animals | 1 | 2023 | 37642 | 0.010 |
Why?
| | Neoadjuvant Therapy | 1 | 2002 | 427 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2002 | 1243 | 0.010 |
Why?
| | Diet | 1 | 2006 | 1269 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2002 | 1398 | 0.010 |
Why?
| | Survival Rate | 1 | 2002 | 1973 | 0.010 |
Why?
|
|
Scott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|